Fausto Pivetti
18Patents
3h-index
34Co-inventors
60Inventor score
Filing activity: Aug 2, 1999 → May 6, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9434691B2 | Process for the preparation of a PDE4 inhibitor | Chemistry; Metallurgy | 5 | Active |
| US7381402B2 | Stable pharmaceutical solution formulations for pressurized metered dose inhalers | Human Necessities | 4 | Expired |
| US8076505B2 | Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid | Chemistry; Metallurgy | 4 | Active |
| US10323003B2 | Process for the preparation of a PDE4 inhibitor | Chemistry; Metallurgy | 3 | Active |
| US9890122B2 | Process for the preparation of a PDE4 inhibitor | Chemistry; Metallurgy | 3 | Active |
| US9056818B2 | Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid | Chemistry; Metallurgy | 3 | Active |
| US10759761B2 | Process for the preparation of a PDE4 inhibitor | Chemistry; Metallurgy | 2 | Active |
| US8399406B2 | Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C) | Human Necessities | 1 | Active |
| US10350164B2 | Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | Human Necessities | 1 | Active |
| US11352327B2 | Process for the preparation of a PDE4 inhibitor | Chemistry; Metallurgy | 1 | Active |
| US10786450B2 | Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | Human Necessities | 0 | Active |
| US8163922B2 | Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride | Emerging Cross-Sectional Technologies | 0 | Active |
| US11981639B2 | Process for the preparation of a PDE4 inhibitor | Chemistry; Metallurgy | 0 | Active |
| US8673978B2 | Polymorphs and salts | Chemistry; Metallurgy | 0 | Active |
| US9174937B2 | Crystal form of glycopyrronium chloride | Human Necessities | 0 | Active |
| US8877164B2 | Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent | Human Necessities | 0 | Active |
| US8128909B2 | Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation | Chemistry; Metallurgy | 0 | Active |
| US6297237A | Process for the preparation of aminocarbonyl derivatives of geneseroline having selective brain anticholinesterase activity | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.